ADVERSE SIDE EFFECTS OF TUBERCULOSIS ETIOTROPIC TREATMENT REGIMENS CONTAINING THE NEW ANTI-TUBERCULOSIS DRUG OF SQ109
.
Main Author: | S. E. Borisov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2018-08-01
|
Series: | Туберкулез и болезни лёгких |
Online Access: | https://www.tibl-journal.com/jour/article/view/1156 |
Similar Items
-
EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: S. E. Borisov, et al.
Published: (2018-04-01) -
Improved Synthesis of the Antitubercular Agent SQ109
by: Marianna Stampolaki, et al.
Published: (2021-12-01) -
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
by: Sergey Bukhdruker, et al.
Published: (2020-10-01) -
Validity and reliability of “Short-questionnaire of tuberculosis patients’ knowledge about anti-tuberculosis and hepatotoxicity” (SQ-KSH-TB)
by: Dyah Aryani Perwitasari, et al.
Published: (2023-03-01) -
TO DISCONTINUE OR TO WAIT?: INDICATIONS FOR DISCONTINUATION OF ANTI-TUBERCULOSIS DRUGS DUE TO ADVERSE EVENTS
by: D. A. Ivаnovа, et al.
Published: (2018-03-01)